BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 169035)

  • 1. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

  • 2. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
    Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD
    Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine.
    Derge JG; Martos LM; Tagamets MA; Chang SY; Chakrabarty M
    Nat New Biol; 1973 Aug; 244(137):214-7. PubMed ID: 4353682
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of Epstein-Barr virus-related membrane antigens by 5-iododeoxyuridine in non-producer human lymphoblastoid cells.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1973 Nov; 246(151):70-2. PubMed ID: 4357308
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid.
    Yajima Y; Tanaka A; Nonoyama M
    Virology; 1976 May; 71(1):352-4. PubMed ID: 179207
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the resistance of Fpstein-Barr virus DNA synthesis to hydroxyurea.
    Mele J; Glaser R; Nonoyama M; Zimmerman J; Rapp F
    Virology; 1974 Nov; 62(1):102-11. PubMed ID: 4371583
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.
    Nyormoi O; Thorley-Lawson DA; Elkington J; Strominger JL
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1745-8. PubMed ID: 179098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
    Summers WC; Klein G
    J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of efficiency of various methods of induction of Epstein-Barr virus antigens synthesis in human lymphoblastoid cell lines].
    Prachová K
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jul; 31(4):236-41. PubMed ID: 6288272
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunofluorescent antigen associated with Epstein-Barr virus induced by 5-Iododeoxyuridine.
    Sugawara K; Osato T
    Nat New Biol; 1973 Nov; 246(151):72-3. PubMed ID: 4357309
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of Epstein-Barr virus antigens and DNA in activated Burkitt somatic cell hybrids.
    Glaser R; Nonoyama M; Decker B; Rapp F
    Virology; 1973 Sep; 55(1):62-9. PubMed ID: 4353957
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr virus carried by Raji cells: a mutant in early functions?
    Kallin B; Klein G
    Intervirology; 1983; 19(1):47-51. PubMed ID: 6298144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual persistence of Epstein-Barr viral and type-C viral genomes in nonproducer human lymphoblastoid cells.
    Osato T; Yamamoto K; Mizuno F; Sugawara K; Aya T
    Bibl Haematol; 1975; (40):585-8. PubMed ID: 169826
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine.
    Hampar B; Lenoir G; Nonoyama M; Derger JG; Chang S
    Virology; 1976 Feb; 69(2):660-8. PubMed ID: 176789
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines.
    Lin JC; Smith MC; Choi EI; De Clercq E; Verbruggen A; Pagano JS
    Antiviral Res; 1985; Suppl 1():121-6. PubMed ID: 3002251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Epstein-Barr virus antigens in human lymphoblastoid P3HR-1 cells with culture fluid of Fusobacterium nucleatum.
    Ito Y; Kishishita M; Yanase S
    Cancer Res; 1980 Nov; 40(11):4329-30. PubMed ID: 6258779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the host cell on the maintenance and replication of Epstein-Barr virus.
    Glaser R; Farrugia R; Brown N
    Virology; 1976 Jan; 69(1):132-42. PubMed ID: 174288
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.